Terms: = Colorectal cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338
33 results:
1. YAP/TAZ enhances P-body formation to promote tumorigenesis.
Shen X; Peng X; Guo Y; Dai Z; Cui L; Yu W; Liu Y; Liu CY
Elife; 2024 Jul; 12():. PubMed ID: 39046443
[TBL] [Abstract] [Full Text] [Related]
2. Energy stress promotes P-bodies formation via lysine-63-linked polyubiquitination of HAX1.
Zhan W; Li Z; Zhang J; Liu Y; Liu G; Li B; Shen R; Jiang Y; Shang W; Gao S; Wu H; Wang Y; Chen W; Wang Z
EMBO J; 2024 Jul; 43(13):2759-2788. PubMed ID: 38769438
[TBL] [Abstract] [Full Text] [Related]
3. Raman Imaging-A Valuable Tool for Tracking Fatty Acid Metabolism-Normal and cancer Human Colon Single-Cell Study.
Beton-Mysur K; Kopec M; Brozek-Pluska B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674093
[TBL] [Abstract] [Full Text] [Related]
4. Raman-AFM-fluorescence-guided impact of linoleic and eicosapentaenoic acids on subcellular structure and chemical composition of normal and cancer human colon cells.
Beton-Mysur K; Surmacki J; Brożek-Płuska B
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jul; 315():124242. PubMed ID: 38581725
[TBL] [Abstract] [Full Text] [Related]
5. Breath Fingerprint of colorectal cancer Patients Based on the Gas Chromatography-Mass Spectrometry Analysis.
Kononova E; Mežmale L; Poļaka I; Veliks V; Anarkulova L; Vilkoite I; Tolmanis I; Ļeščinska AM; Stonāns I; Pčolkins A; Mochalski P; Leja M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338911
[TBL] [Abstract] [Full Text] [Related]
6. Pooled CRISPR Screening Identifies P-Bodies as Repressors of cancer Epithelial-Mesenchymal Transition.
Fang L; Zhang L; Wang M; He Y; Yang J; Huang Z; Tan Y; Fang K; Li J; Sun Z; Li Y; Tang Y; Liang W; Cui H; Zhu Q; Wu Z; Li Y; Hu Y; Chen W
Cancer Res; 2024 Mar; 84(5):659-674. PubMed ID: 38190710
[TBL] [Abstract] [Full Text] [Related]
7. Expression and correlation of COX-2 and NUCB1 in colorectal adenocarcinoma.
Zhang Y; Zhang G; Zhong J; Li A; Wu Y; Guo Z
PeerJ; 2023; 11():e15774. PubMed ID: 37547718
[TBL] [Abstract] [Full Text] [Related]
8. Financial Toxicities Persist for cancer Survivors Irrespective of Current cancer Status: An Analysis of Medical Expenditure Panel Survey.
Karim MA; Talluri R; Shastri SS; Kum HC; Shete S
Cancer Res Commun; 2022 Oct; 2(10):1119-1128. PubMed ID: 36531523
[TBL] [Abstract] [Full Text] [Related]
9. Inducing Hypermutability to Promote Anti-PD-1 Therapy Response.
Willis JA; Overman MJ
Cancer Discov; 2022 Jul; 12(7):1612-1614. PubMed ID: 35791694
[TBL] [Abstract] [Full Text] [Related]
10. Pathologic complete response is associated with decreased morbidity following rectal cancer resection.
Wolf JH; Hung YC; Cox S; Aghedo B; Mavanur A; Svoboda S; D'Adamo CR
Am J Surg; 2021 Aug; 222(2):390-394. PubMed ID: 33261851
[TBL] [Abstract] [Full Text] [Related]
11. Is repeated pulmonary metastasectomy justified?
Forster C; Ojanguren A; Perentes JY; Zellweger M; Federici S; Krueger T; Abdelnour-Berchtold E; Gonzalez M
Clin Exp Metastasis; 2020 Dec; 37(6):675-682. PubMed ID: 32920725
[TBL] [Abstract] [Full Text] [Related]
12. Predicting Risk of Recurrence After colorectal cancer Surgery in the United States: An Analysis of a Special Commission on cancer National Study.
Zafar SN; Hu CY; Snyder RA; Cuddy A; You YN; Lowenstein LM; Volk RJ; Chang GJ
Ann Surg Oncol; 2020 Aug; 27(8):2740-2749. PubMed ID: 32080809
[TBL] [Abstract] [Full Text] [Related]
13. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.
Dienstmann R; Villacampa G; Sveen A; Mason MJ; Niedzwiecki D; Nesbakken A; Moreno V; Warren RS; Lothe RA; Guinney J
Ann Oncol; 2019 Oct; 30(10):1622-1629. PubMed ID: 31504112
[TBL] [Abstract] [Full Text] [Related]
14. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric cancer Cells by Suppressing KRAS Networks Including ddx6 RNA Helicase.
Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
[TBL] [Abstract] [Full Text] [Related]
15. Pedunculated Morphology of T1 colorectal Tumors Associates With Reduced Risk of Adverse Outcome.
Kessels K; Backes Y; Elias SG; van den Blink A; Offerhaus GJA; van Bergeijk JD; Groen JN; Seerden TCJ; Schwartz MP; de Vos Tot Nederveen Cappel WH; Spanier BWM; Geesing JMJ; Kerkhof M; Siersema PD; Didden P; Boonstra JJ; Herrero LA; Wolfhagen FHJ; Ter Borg F; van Lent AU; Terhaar Sive Droste JS; Hazen WL; Schrauwen RWM; Vleggaar FP; Laclé MM; Moons LMG;
Clin Gastroenterol Hepatol; 2019 May; 17(6):1112-1120.e1. PubMed ID: 30130623
[TBL] [Abstract] [Full Text] [Related]
16. DEAD-Box Protein RNA-Helicase ddx6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric cancer Cells.
Tajirika T; Tokumaru Y; Taniguchi K; Sugito N; Matsuhashi N; Futamura M; Yanagihara K; Akao Y; Yoshida K
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987267
[TBL] [Abstract] [Full Text] [Related]
17. Oncogene RNA helicase ddx6 promotes the process of c-Myc expression in gastric cancer cells.
Taniguchi K; Iwatsuki A; Sugito N; Shinohara H; Kuranaga Y; Oshikawa Y; Tajirika T; Futamura M; Yoshida K; Uchiyama K; Akao Y
Mol Carcinog; 2018 May; 57(5):579-589. PubMed ID: 29314290
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe.
Freisling H; Arnold M; Soerjomataram I; O'Doherty MG; Ordóñez-Mena JM; Bamia C; Kampman E; Leitzmann M; Romieu I; Kee F; Tsilidis K; Tjønneland A; Trichopoulou A; Boffetta P; Benetou V; Bueno-de-Mesquita HBA; Huerta JM; Brenner H; Wilsgaard T; Jenab M
Br J Cancer; 2017 May; 116(11):1486-1497. PubMed ID: 28441380
[TBL] [Abstract] [Full Text] [Related]
19. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
[TBL] [Abstract] [Full Text] [Related]
20. Strategies for Increasing Pancreatic Tumor Immunogenicity.
Johnson BA; Yarchoan M; Lee V; Laheru DA; Jaffee EM
Clin Cancer Res; 2017 Apr; 23(7):1656-1669. PubMed ID: 28373364
[TBL] [Abstract] [Full Text] [Related]
[Next]
